What happened at ISCT 2022’s return to in-person conferencing – and what can a new film release do for advanced therapy?

The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight

In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many

An inside view of the pharmaceutical industry in China. Where has it been, where does it stand, and where is it going?

A new method for muting malaria turns one of the parasite’s proteins into a self-destruction device

The DNDi is doing incredible work across the world. In this digital feature, we explore a portion of these open science efforts.

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown